Emily Guo, MD
Dermatology · Houston, TXNPI 1861921280
Payments from drug & device makers
Across 310 payments — averaging $70.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solta Medical, A Division Of Bausch Health US, LLC$11K
- Merz North America, Inc.$3K
- AbbVie$3K
- Sanofi$790
- Amgen$719
- Johnson & Johnson$504
- plus $3K from 18 others
What the payments were for
- Consulting fees$1,2206%
- Speaking & faculty fees$10,50048%
- Travel & lodging$1,0105%
- Food & beverage$9,05541%
- Education$1841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solta Medical, A Division Of Bausch Health US, LLC | 11 | $10,746 |
| Merz North America, Inc. | 11 | $2,995 |
| AbbVie(2 entities) | 81 | $2,882 |
| Sanofi | 27 | $790 |
| Amgen | 27 | $719 |
| Johnson & Johnson | 21 | $504 |
| Arcutis Biotherapeutics, Inc. | 19 | $466 |
| LEO Pharma Inc. | 23 | $431 |
| Sun Pharmaceutical Industries Inc. | 15 | $427 |
| Regeneron Healthcare Solutions, Inc. | 7 | $403 |
| Novartis | 12 | $327 |
| Galderma Laboratories, L.p. | 18 | $270 |
| Incyte Corporation | 10 | $242 |
| E.r. Squibb & Sons, L.L.C. | 9 | $185 |
| Lilly USA, LLC | 6 | $150 |
| Revance Therapeutics, Inc. | 1 | $113 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Mayne Pharma Commercial LLC | 2 | $48 |
| Pfizer | 3 | $44 |
| Organon | 1 | $36 |
| Botanix SB Inc | 2 | $32 |
| EPI Health, LLC | 1 | $27 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Journey Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,970 in reported general payments places this provider in the 80th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 28 | $496 |
| Triamcinolone Acetonide | 25 | $325 |
| Doxycycline Hyclate | 16 | $245 |
| Mupirocin | 28 | $196 |
| Minoxidil | 16 | $81 |
| Hydrocortisone | 20 | $72 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Houston
- Michael MigdenHouston$3.7M
- Megan CouvillionHouston$3M
- Alpesh DesaiHouston$2.7M
- Suzanne BruceHouston$2.2M
- Geeta PatelHouston$626K
- Madeleine DuvicHouston$597K
- Auris HuenHouston$323K
- Catherine PapasakelariouHouston$289K
- Anisha PatelHouston$268K
- Stephen TyringWebster$14.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.